ASEP Medical Holdings Inc.
SEPSF
$0.39
-$0.21-35.50%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.90% | -4.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.90% | -4.49% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 4.90% | -4.49% | |||
| SG&A Expenses | -24.38% | 4.00% | |||
| Depreciation & Amortization | 2.26% | -46.34% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -16.59% | -19.47% | |||
| Operating Income | 18.99% | 20.85% | |||
| Income Before Tax | -81.97% | 93.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -81.97% | 93.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 137.84% | -98.92% | |||
| Net Income | -77.25% | 89.20% | |||
| EBIT | 18.99% | 20.85% | |||
| EBITDA | 26.99% | 3.72% | |||
| EPS Basic | -32.96% | 89.84% | |||
| Normalized Basic EPS | 53.56% | -108.12% | |||
| EPS Diluted | -32.96% | 89.84% | |||
| Normalized Diluted EPS | 53.56% | -108.12% | |||
| Average Basic Shares Outstanding | 33.22% | 6.36% | |||
| Average Diluted Shares Outstanding | 33.22% | 6.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||